Zobrazeno 1 - 10
of 72
pro vyhledávání: '"C. Paul Morrow"'
Autor:
C. Paul Morrow, Annie A. Yessaian, Koji Matsuo, Yvonne G. Lin, Laila I. Muderspach, Huyen Q. Pham, Lynda D. Roman, Howard A. Liebman
Publikováno v:
Gynecologic Oncology. 128:544-551
To profile characteristics and survival of endometrial cancer patients who develop venous thromboembolism (VTE) and to establish a predictive model of VTE in endometrial cancer.Cases were identified using an institutional database between 2000 and 20
Publikováno v:
Gynecologic Oncology. 95:189-192
Objectives. To describe our experience with extraperitoneal lymph node staging in gynecologic oncology. Materials and methods. The extraperitoneal approach was performed to assess the lymph node histology in patients with gynecologic malignancies. Th
Autor:
C. Paul Morrow, Alexander Burnett, Tamar Safra, Linyun Zhou, Franco M. Muggia, Susan Groshen, Lynda Roman, R N Susan Jeffers, Denice D. Tsao-Wei, Laila Muderspach
Publikováno v:
Cancer. 91:90-100
BACKGROUND Pegylated liposomal doxorubicin is a new formulation with activity against epithelial ovarian carcinoma (EOC). The authors sought to determine patient characteristics that may predict for response to this treatment and favorable time to fa
Autor:
C. Paul Morrow, George E. Smart
This collection of papers on different aspects of gynaecological oncology is taken from the proceedings of the Second International Conference on Gynaecological Cancer held in Edinburgh in Sep tember 1983. An attempt has been made to include topica
Autor:
Laila I. Muderspach, T. Safra, Lynda D. Roman, Rosemerlinda Rosales, Susan Groshen, Franco M. Muggia, C. Paul Morrow, Susan Jeffers
Publikováno v:
Gynecologic Oncology. 66:290-294
Previous studies have shown that intraperitoneal (i.p.) floxuridine (FUDR) is tolerated at a dose of 3 g x 3 days given in 1.5-2 L of normal saline (NS). In a randomized phase II trial by the Southwest Oncology Group, this treatment was selected for
Publikováno v:
Cancer. 77:1115-1121
BACKGROUND Numerous pathologic factors have been identified as important in predicting outcome for women with endometrial adenocarcinoma. However, most patients have a mixture of good and bad factors. For these women, the prognosis is uncertain, and
Publikováno v:
Cancer. 75:81-86
Background. The histologic grade of endometrial adenocarcinoma is related to the aggressiveness of the tumor and probability of death from disease. However, the ideal system for assignment of histologic grade remains controversial. In 1988, the Inter
Autor:
Fernando Fleischman, Charles A. Ballard, Lynda D. Roman, Anna S. Gabrielyan, C. Paul Morrow, Christian S. Ghattas, Koji Matsuo
Publikováno v:
Fertility and sterility. 98(5)
Objective To report a conservative surgical management of cardiac-extending intravenous (IV) leiomyomatosis. Design Case report. Setting Tertiary care center. Patient(s) A 40-year-old nulligravid with incidentally identified IV leiomyomatosis arising